CSTL - Company ID 0001447362
The table below shows CASTLE BIOSCIENCES INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $83.68M | $83.04M | $86.19M | $87.99M | $85.78M | $87.00M |
| Cost of revenue | $20.53M | $18.70M | $17.63M | $16.38M | $15.61M | $14.52M |
| Gross profit | - | - | - | - | - | - |
| R&D | $14.43M | $12.96M | $12.79M | $12.59M | $12.32M | $14.14M |
CASTLE BIOSCIENCES INC reported annual revenue of $344.23M for fiscal year 2025. That is up 3.7% from $332.07M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $22.79M (FY 2018) to $344.23M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $64.90M |
| $55.91M |
| $58.06M |
| $58.62M |
| $50.50M |
| $51.09M |
| Operating income | -$18.41M | -$6.80M | -$4.25M | -$27.93M | $5.08M | $5.01M |
| Income tax | $109.00K | $115.00K | -$4.67M | -$423.00K | $6.01M | -$1.03M |
| Net income | -$14.52M | -$501.00K | $4.52M | -$25.85M | $2.27M | $8.92M |
| EPS (diluted) | -$0.49 | -$0.02 | $0.15 | -$0.90 | $0.08 | $0.31 |